Novavax

Novavax, Inc.
legal form	Inc.
ISIN	US6700024010
founding	1987
Seat	Gaithersburg , Maryland
management	Stanley C. Erck (CEO)
Number of employees	165
sales	19 million US dollars
Branch	biotechnology
Website	www.novavax.com
	As of December 31, 2019

Novavax is a US pharmaceutical company specializing in the development of vaccines . It is headquartered in Gaithersburg in Maryland and additional facilities in Rockville (Maryland) and Uppsala ( Sweden ). Novavax is listed on NASDAQ .

The company's product pipeline is focused on a range of infectious diseases with vaccine candidates in clinical development for Respiratory Syncytial Virus (RSV), seasonal flu , pandemic flu and Ebola virus . In 2015, the company received a $ 89 million grant from the Bill & Melinda Gates Foundation to help develop a vaccine against respiratory syncytial virus for young children through maternal immunization. In 2019, however, the development of a vaccine against the respiratory syncytial virus failed a second time.

In January 2020, Novavax announced the development of a vaccine candidate named NVX-CoV2373 to inhibit SARS-CoV-2 , which is competing with dozens of other companies to develop a vaccine. In March 2020, Novavax announced a collaboration with Emergent BioSolutions for preclinical and early human research on the vaccine candidate. As part of the partnership, Emergent BioSolutions will manufacture the vaccine on a large scale at their Baltimore facility . In July 2020, Novavax received $ 1.6 billion from the American government for this. 100 million vaccine doses are to be produced by the beginning of 2021.

Individual evidence

↑ Novavax Revenue 2006-2020 | NVAX. Retrieved July 7, 2020 .
↑ Novavax Inc. receives grant worth up to $ 89 million grant from Bill and Melinda Gates Foundation - Washington Business Journal . In: Washington Business Journal . ( bizjournals.com [accessed July 7, 2020]).
↑ Contributor George Budwell The Motley Fool: 3 Top Biotech Picks for 2020. Accessed July 7, 2020 .
^ Robert McCartney: Maryland plays an outsized role in worldwide hunt for a coronavirus vaccine. Retrieved July 7, 2020 .
^ Deutscher Ärzteverlag GmbH, editorial office of the Deutsches Ärzteblatt: Novavax receives 1.6 billion dollars for vaccine. July 7, 2020, accessed July 7, 2020 .

[1] Novavax Revenue 2006-2020 | NVAX. Retrieved July 7, 2020 .

[2] Novavax Inc. receives grant worth up to $ 89 million grant from Bill and Melinda Gates Foundation - Washington Business Journal . In: Washington Business Journal . ( bizjournals.com [accessed July 7, 2020]).

[3] Contributor George Budwell The Motley Fool: 3 Top Biotech Picks for 2020. Accessed July 7, 2020 .

[4] Robert McCartney: Maryland plays an outsized role in worldwide hunt for a coronavirus vaccine. Retrieved July 7, 2020 .

[5] Deutscher Ärzteverlag GmbH, editorial office of the Deutsches Ärzteblatt: Novavax receives 1.6 billion dollars for vaccine. July 7, 2020, accessed July 7, 2020 .